文献库搜索 | GeneLibs

Nizamuddin(N),Biswas(S),Zawar(A),Deshpande... Front Syst Biol None

...BRCA1/BRCA2 variants from the BRCA Exchange database, completely independent of the ClinVar training data demonstrated a...

Chen(R),Ge(C),Yuan(F),Fu(K),Long(X),Wu(K),... Expert Rev Mol Diagn 2026-08-21

...BRCA1/2 variant with a pathogenic mismatch-repair (MMR) variant, but current guidelines manage the two inherited pathway...

Perumalsamy(B),Vengoji(R),Thiraviyam(A),Ra... Neuro Oncol 2026-08-19

...BRCA1) and stemness (CD44, KLF4, c-Myc, and BMI1) revealed Abx decreased chromatin accessibility. Abx decreased stem cel...

Viveros-Carreño(D),Mora-Soto(N),Beshar(I),... Int J Gynecol Cancer 2026-08-03

Hereditary tubo-ovarian cancer risk assessment has evolved from a BRCA1/2-centered consultation to an integrated prevent...

Posite(CM),Wabinga(H),Atwine(R),Vahwere(BM... Clin Genitourin Cancer 2026-07-28

...BRCA1/2 was noted in high-grade tumors. All included studies demonstrated a low risk of bias, though confounding managem...

Canbek(S),Karaağaç(M),Ermiş(A),Türkan(Ş),T... Mol Biol Rep 2026-08-21

...BRCA1/2, the study analyzed tumor characteristics, metastatic status, and receptor expression in patients harboring ERCC...

Pai(AKA),Dcunha(L),Gopalakrishnan(AP),Umma... Front Syst Biol None

...BRCA1, RAD51AP1, NBN, PNKP, TP53BP1, and PBRM1. UALCAN analysis further revealed differential regulation of SMG1 phospho...

Alsaati(B),Ujaimi(R),Trabulsi(N),Abusanad(... Case Rep Oncol None

...BRCA1/2 testing was negative. She underwent four cycles of neoadjuvant doxorubicin/cyclophosphamide with limited respons...

Zhan(B),Zhong(Y),Chen(X),Dai(Y),Du(L),Lin(... Bioorg Chem 2026-08-18

...BRCA1/2-mutant tumors, has emerged as an effective strategy for cancer therapy. GEN1, a structure-selective endonuclease...

Wang(J),Lu(Z),Ge(M),Zhang(X),Chen(D),Peng(... Clin Lung Cancer 2026-07-27

...BRCA1 being particularly prominent. Immunologically, LOLC tumors exhibited higher TMB and PD-L1 positivity. Integrated p...